Nephrotic syndrome associated with ramucirumab therapy: A single-center case series and literature review
2019
AbstractRamucirumab is a human immunoglobulin G1 monoclonal antibody that binds to vascular endothelial growth factor receptor 2 and is used for the treatment of metastatic or inoperable gastric, colorectal, and non-small cell lung cancers. However, ramucirumab can result in renal adverse events, in
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
28
References
7
Citations
NaN
KQI